relative to prescriptions for certain controlled drugs.

HB 126 limits most prescriptions for Schedule II and III controlled drugs to a 34-day supply per pharmacy fill, affecting pharmacists and patients using these medications. Exceptions allow up to 60 days for certain commercially packaged products (like metered inhalers), 90 days for amphetamines treating ADHD or narcolepsy, and 92 days for topical or injectable androgens used for chronic low testosterone. The bill aims to standardize prescription durations while maintaining access for specific medical treatments. It does not change which drugs are prescribed but regulates how much can be dispensed at one time.